Editorial: Pathogenic mechanisms, injury biomarkers, prophylaxis and treatment strategy of drug-induced nephrotoxicity.
作者信息
Jiao Guozheng, Niu Yimin, Wang Bin
机构信息
Chemistry and Chemical Engineering Institute, Taishan University, Tai'an, Shandong, China.
Department of Pharmacy, Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China.
出版信息
Front Med (Lausanne). 2024 Apr 29;11:1412795. doi: 10.3389/fmed.2024.1412795. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Pathogenic mechanisms, injury biomarkers, prophylaxis and treatment strategy of drug-induced nephrotoxicity.
Front Med (Lausanne). 2024 Apr 29;11:1412795. doi: 10.3389/fmed.2024.1412795. eCollection 2024.
2
Drug-Induced Nephrotoxicity: Pathogenic Mechanisms, Biomarkers and Prevention Strategies.
Curr Drug Metab. 2018;19(7):559-567. doi: 10.2174/1389200218666171108154419.
3
Ezetimibe ameliorates cisplatin-induced nephrotoxicity: A novel therapeutic approach via modulating AMPK/Nrf2/TXNIP signaling.
FASEB J. 2024 Jan;38(1):e23382. doi: 10.1096/fj.202302019R.
4
Targeting NEDDylation is a Novel Strategy to Attenuate Cisplatin-induced Nephrotoxicity.
Cancer Res Commun. 2023 Feb 13;3(2):245-257. doi: 10.1158/2767-9764.CRC-22-0340. eCollection 2023 Feb.
5
Nod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via thioredoxin-interacting protein (TXNIP) during hyperhomocysteinemia.
J Biol Chem. 2014 Sep 26;289(39):27159-27168. doi: 10.1074/jbc.M114.567537. Epub 2014 Aug 19.
6
The effect of high glucose-based peritoneal dialysis fluids on thioredoxin-interacting protein expression in human peritoneal mesothelial cells.
Int Immunopharmacol. 2019 Jan;66:198-204. doi: 10.1016/j.intimp.2018.11.027. Epub 2018 Nov 22.
7
Thioredoxin and thioredoxin-interacting protein as prognostic markers for gastric cancer recurrence.
World J Gastroenterol. 2012 Oct 21;18(39):5581-8. doi: 10.3748/wjg.v18.i39.5581.
8
Thioredoxin-interacting protein links endoplasmic reticulum stress to inflammatory brain injury and apoptosis after subarachnoid haemorrhage.
J Neuroinflammation. 2017 May 11;14(1):104. doi: 10.1186/s12974-017-0878-6.
9
The Emerging Role of Thioredoxin-Interacting Protein in Myocardial Ischemia/Reperfusion Injury.
J Cardiovasc Pharmacol Ther. 2017 May;22(3):219-229. doi: 10.1177/1074248416675731. Epub 2016 Nov 2.
10
Thioredoxin-Interacting Protein (TXNIP) in Cerebrovascular and Neurodegenerative Diseases: Regulation and Implication.
Mol Neurobiol. 2018 Oct;55(10):7900-7920. doi: 10.1007/s12035-018-0917-z. Epub 2018 Feb 27.
本文引用的文献
1
Generation of a drug-induced renal injury list to facilitate the development of new approach methodologies for nephrotoxicity.
Drug Discov Today. 2024 Apr;29(4):103938. doi: 10.1016/j.drudis.2024.103938. Epub 2024 Mar 1.
2
A DNA nanostructure-Hif-1α inducer complex as novel nanotherapy against cisplatin-induced acute kidney injury.
Cell Prolif. 2024 Jun;57(6):e13601. doi: 10.1111/cpr.13601. Epub 2024 Jan 14.
3
Protective effects of natural products against drug-induced nephrotoxicity: A review in recent years.
Food Chem Toxicol. 2021 Jul;153:112255. doi: 10.1016/j.fct.2021.112255. Epub 2021 May 11.
4
Global epidemiology and outcomes of acute kidney injury.
Nat Rev Nephrol. 2018 Oct;14(10):607-625. doi: 10.1038/s41581-018-0052-0.
5
Drug-Induced Nephrotoxicity and Drug Metabolism in Renal Failure.
Curr Drug Metab. 2018;19(7):558. doi: 10.2174/138920021907180709121120.
6
Drug-Induced Nephrotoxicity: Pathogenic Mechanisms, Biomarkers and Prevention Strategies.
Curr Drug Metab. 2018;19(7):559-567. doi: 10.2174/1389200218666171108154419.
7
A Multiplatform Approach for the Discovery of Novel Drug-Induced Kidney Injury Biomarkers.
Chem Res Toxicol. 2017 Oct 16;30(10):1823-1834. doi: 10.1021/acs.chemrestox.7b00159. Epub 2017 Sep 27.
8
Drug-induced Nephrotoxicity and Medicinal Plants.
Iran J Kidney Dis. 2017 May;11(3):169-179.
9
Drug-induced nephrotoxicity: clinical impact and preclinical in vitro models.
Mol Pharm. 2014 Jul 7;11(7):1933-48. doi: 10.1021/mp400720w. Epub 2014 Mar 3.
Zotero 插件